InvestSMART

Pharmaxis Ltd (ASX: PXS) - Announcements

- Current share price for PXS : $0.027

ASX company news and announcements for Pharmaxis Ltd (PXS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pharmaxis Ltd (PXS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pharmaxis Ltd (PXS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pharmaxis Ltd (PXS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3B - performance rights and employee share plan 31 Jul 2015 8:51AM $0.225 $0.027 fallen by 88%
- Appendix 3B - exercise of employee options 31 Jul 2015 8:49AM $0.225 $0.027 fallen by 88%
- Appendix 4C - quarterly 31 Jul 2015 8:42AM $0.225 $0.027 fallen by 88%
- Quarterly Shareholder Update - June 2015 31 Jul 2015 8:41AM $0.225 $0.027 fallen by 88%
- Becoming a substantial holder 1 Jul 2015 10:22AM $0.230 $0.027 fallen by 88.26%
- 29-06-2015 - Appendix 3B - exercise of employee options 29 Jun 2015 8:39AM $0.230 $0.027 fallen by 88.26%
- Pharmaxis Share Trading Policy - updated June 2015 19 Jun 2015 4:43PM $0.230 $0.027 fallen by 88.26%
- Change in substantial holding 18 Jun 2015 8:27AM $0.230 $0.027 fallen by 88.26%
- Ceasing to be a substantial holder from AEF 15 Jun 2015 4:47PM $0.230 $0.027 fallen by 88.26%
- Change in substantial holding 12 Jun 2015 8:26AM $0.230 $0.027 fallen by 88.26%
- Change in substantial holding 9 Jun 2015 8:23AM $0.230 $0.027 fallen by 88.26%
- Becoming a substantial holder 5 Jun 2015 8:27AM $0.230 $0.027 fallen by 88.26%
- Appendix 3B - exercise of employee options 1 Jun 2015 5:09PM $0.230 $0.027 fallen by 88.26%
- Change of Director's Interest Notice 27 May 2015 3:35PM $0.233 $0.027 fallen by 88.39%
- Investor Presentation 19 May 2015 10:02AM $0.250 $0.027 fallen by 89.20%
- PXS Announces Completion of Restructuring and New Focus 19 May 2015 10:02AM $0.250 $0.027 fallen by 89.20%
- Appendix 3B - exercise of employee options 18 May 2015 4:02PM $0.250 $0.027 fallen by 89.20%
- Boehringer Ingelheim acquires Pharmaxis phase 1 drug 18 May 2015 8:43AM $0.165 $0.027 fallen by 83.64%
- Appendix 3B - Exercise of employee options 11 May 2015 8:30AM $0.175 $0.027 fallen by 84.57%
- Pharmaxis Signs Second Agreement with Chiesi 8 May 2015 8:29AM $0.165 $0.027 fallen by 83.64%
- Change in substantial holding from NAB 24 Apr 2015 5:18PM $0.170 $0.027 fallen by 84.12%
- Appendix 3B - Exercise of employee options 24 Apr 2015 3:39PM $0.180 $0.027 fallen by 85%
- Change in substantial holding from AEF - correction 21 Apr 2015 4:12PM $0.180 $0.027 fallen by 85%
- Change in substantial holding from AEF 21 Apr 2015 2:10PM $0.185 $0.027 fallen by 85.41%
- Appendix 4C - quarterly cash flow 17 Apr 2015 8:42AM n/a $0.027 n/a

576 - 600 of 836 results

Page 24 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.